Does Methylphenidate Cause Genetic Damage in Children with ADHD?
Author Information
Author(s): Walitza Susanne, Werner Birgit, Romanos Marcel, Warnke Andreas, Gerlach Manfred, Stopper Helga
Primary Institution: University of Würzburg
Hypothesis
Does methylphenidate treatment cause cytogenetic effects in children with ADHD?
Conclusion
The study found no significant increase in genomic damage in children treated with methylphenidate.
Supporting Evidence
- MPH treatment resulted in no significant alteration in the micronucleus frequency.
- The findings from this study did not replicate previous concerns about MPH causing genomic damage.
- Children in the chronic treatment group showed no significant difference in micronucleated cells compared to pretreatment values.
Takeaway
The study looked at whether a medicine called methylphenidate, used for kids with ADHD, causes any harm to their genes. It found that it doesn't.
Methodology
The study analyzed genomic damage in children with ADHD before and after starting methylphenidate therapy, measuring micronuclei in blood samples.
Potential Biases
Potential bias due to the lack of diversity in the participant demographics.
Limitations
The study had a small sample size and limited follow-up duration.
Participant Demographics
The participants were 38 children with ADHD, predominantly male, aged 4.9 to 17 years, all of German origin.
Statistical Information
P-Value
p=0.49
Statistical Significance
p>0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website